MiR-21 was also shown to target several components of p53, TGF-β and mitochondrial apoptotic networks, in order to decrease apoptotic activation in GBM cells [71], and to enhance tumor cell migration by inhibiting the matrix metalloproteinase (MMP) regulators RECK and TIMP3 [72]. Here, TP53 is linked to neoplasm.